Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock* - Concepedia

Concepedia

Publication | Closed Access

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

917

Citations

22

References

2004

Year

Ángel Crespo López, José A. Lorente, Jay S. Steingrub, Jan Bakker, Angela McLuckie, Sheila M. Willatts, Michael Brockway, Antonio Anzueto, Laurent Holzapfel, Desmond P. Breen,

Critical Care Medicine

Abstract

In this study, the nonselective nitric oxide synthase inhibitor 546C88 increased mortality in patients with septic shock.

References

	Year	Citations

Page 1